Anifrolumab FDA Approval to Treat Systemic Lupus [Saphnelo February 2025 Update]
posted in All on August 2, 2021 by
Updated February 26, 2025
Anifrolumab (Saphnelo) is the 2nd FDA-approved biologic to treat systemic lupus erythematosus (SLE). The first biologic was belimumab (Benlysta).
This article discusses Saphnelo in detail. To compare Saphnelo and Benlysta, see my other article on this topic: lupusencyclopedia.com/saphnelo-vs-benlysta
_______________________…
For more in-depth information on Anifrolumab FDA Approval to Treat Systemic Lupus [Saphnelo February 2025 Update]:
Read more in The Lupus Encyclopedia, edition 2
Look up your symptoms, conditions, and medications in the Index of The Lupus Encyclopedia
If you enjoy the information from The Lupus Encyclopedia, please click the “SUPPORT” button at the top of the page to learn how you can help.
What are your comments and opinions?
If you have lupus, what has your experience been? What do you recommend for other patients?
Do you have any questions to ask Dr. Thomas?
Please click on “Leave a Comment” above to comment.
Please support “The Lupus Encyclopedia” blog post page
Click on “SUPPORT” at the top of the page to learn how you can support “The Lupus Encyclopedia“
Leave a comment